Related references
Note: Only part of the references are listed.Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes
Clio P. Mavragani et al.
JOURNAL OF AUTOIMMUNITY (2018)
2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren's syndrome A consensus and data-driven methodology involving three international patient cohorts
Caroline H. Shiboski et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Immune Diseases Associated with TREX1 and STING Dysfunction
Nan Yan
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2017)
Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens
Xuefeng Liu et al.
NATURE PROTOCOLS (2017)
IFI16 and cGAS cooperate in the activation of STING during DNA sensing in human keratinocytes
Jessica F. Almine et al.
NATURE COMMUNICATIONS (2017)
Interstitial lung disease in primary Sjogren's syndrome
F. Roca et al.
AUTOIMMUNITY REVIEWS (2017)
ILC1 Confer Early Host Protection at Initial Sites of Viral Infection
Orr-El Weizman et al.
CELL (2017)
Innate immunity in Sjogren's syndrome
Jeremy Kiripolsky et al.
CLINICAL IMMUNOLOGY (2017)
Importance of Nucleic Acid Recognition in Inflammation and Autoimmunity
Franck J. Barrat et al.
ANNUAL REVIEW OF MEDICINE, VOL 67 (2016)
Recognition of Endogenous Nucleic Acids by the Innate Immune System
Axel Roers et al.
IMMUNITY (2016)
Diversity and function of group 1 innate lymphoid cells
Victor S. Cortez et al.
IMMUNOLOGY LETTERS (2016)
Association of Antibodies to Interferon-Inducible Protein-16 With Markers of More Severe Disease in Primary Sjogren's Syndrome
Alan N. Baer et al.
ARTHRITIS CARE & RESEARCH (2016)
Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease
Clio P. Mavragani et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Sjogren syndrome
Pilar Brito-Zeron et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Mouse Models of Primary Sjogren's Syndrome
Young-Seok Park et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs
Georg Gasteiger et al.
SCIENCE (2015)
Interferon gamma-inducible protein 16 in primary Sjogren's syndrome: a novel player in disease pathogenesis?
Alessia Alunno et al.
ARTHRITIS RESEARCH & THERAPY (2015)
EBV and other viruses as triggers of tertiary lymphoid structures in primary Sjogren's syndrome
Davide Lucchesi et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2014)
Infection and autoimmunity in Sjogren's syndrome: A clinical study and comprehensive review
Shaye Kivity et al.
JOURNAL OF AUTOIMMUNITY (2014)
Cytosolic-DNA-Mediated, STING-Dependent Proinflammatory Gene Induction Necessitates Canonical NF-κB Activation through TBK1
Takayuki Abe et al.
JOURNAL OF VIROLOGY (2014)
Structure-Function Analysis of STING Activation by c[G(2′,5′) pA(3′,5′)p] and Targeting by Antiviral DMXAA
Pu Gao et al.
CELL (2013)
Mouse, but not Human STING, Binds and Signals in Response to the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid
Joseph Conlon et al.
JOURNAL OF IMMUNOLOGY (2013)
cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING
Andrea Ablasser et al.
NATURE (2013)
5,6-Dimethylxanthenone-4-acetic Acid (DMXAA) Activates Stimulator of Interferon Gene (STING)-dependent Innate Immune Pathways and Is Regulated by Mitochondrial Membrane Potential
Daniel Prantner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
STING Specifies IRF3 Phosphorylation by TBK1 in the Cytosolic DNA Signaling Pathway
Yasuo Tanaka et al.
SCIENCE SIGNALING (2012)
The anti-tumor agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), induces IFN-β-mediated antiviral activity in vitro and in vivo
Kari Ann Shirey et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
Activation of innate immunity accelerates sialoadenitis in a mouse model for Sjogren's syndrome-like disease
S-R Nandula et al.
ORAL DISEASES (2011)
Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines
Shiwen Peng et al.
JOURNAL OF BIOMEDICAL SCIENCE (2011)
Anticancer function of polyinosinic-polycytidylic acid
Yu-Sheng Cheng et al.
CANCER BIOLOGY & THERAPY (2010)
The role of intrinsic epithelial activation in the pathogenesis of Sjogren's syndrome
Menelaos N. Manoussakis et al.
JOURNAL OF AUTOIMMUNITY (2010)
Activation of innate immune responses through Toll-like receptor 3 causes a rapid loss of salivary gland function
Umesh S. Deshmukh et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2009)
Neutrophil Influx and Chemokine Production during the Early Phases of the Antitumor Response to the Vascular Disrupting Agent DMXAA (ASA404)
Liang-Chuan S. Wang et al.
NEOPLASIA (2009)
Proinflammatory cytokines tumor necrosis factor-α and interferon-γ alter tight junction structure and function in the rat parotid gland Par-C10 cell line
Olga J. Baker et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2008)
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
Hiroki Ishikawa et al.
NATURE (2008)
5,6-Dimethylxanthenone-4-acetic acid (DMXAA): a new biological response modifier for cancer therapy
SF Zhou et al.
INVESTIGATIONAL NEW DRUGS (2002)
Share Paper
